Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting

Eleven biologic drugs are currently approved for psoriasis management. Real‐life studies are needed to guide clinicians in choosing a tailored‐tail therapy. The aim of our retrospective study is to indirectly compare the efficacy and safety of ixekizumab and brodalumab in psoriasis patients. A singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Megna, Matteo, Potestio, Luca, Camela, Elisa, Fabbrocini, Gabriella, Ruggiero, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540270/
https://www.ncbi.nlm.nih.gov/pubmed/35762107
http://dx.doi.org/10.1111/dth.15667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540270/
https://www.ncbi.nlm.nih.gov/pubmed/35762107
http://dx.doi.org/10.1111/dth.15667

Ejemplares similares